Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali.

Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali.

<h4>Background</h4>Seasonal malaria chemoprevention (SMC) is now widely deployed in the Sahel, including several countries that are major contributors to the global burden of malaria. Consequently, it is important to understand whether SMC continues to provide a high level of protection...

Full description

Bibliographic Details
Main Authors:	Matthew E Cairns, Issaka Sagara, Issaka Zongo, Irene Kuepfer, Ismaila Thera, Frederic Nikiema, Modibo Diarra, Serge R Yerbanga, Amadou Barry, Amadou Tapily, Samba Coumare, Paul Milligan, Halidou Tinto, Jean Bosco Ouédraogo, Daniel Chandramohan, Brian Greenwood, Abdoulaye Djimde, Alassane Dicko
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-08-01
Series:	PLoS Medicine
Online Access:	https://doi.org/10.1371/journal.pmed.1003214

Similar Items

Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria
by: Mariken de Wit, et al.
Published: (2021-06-01)

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
by: Ismaila Thera, et al.
Published: (2020-09-01)

Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
by: Brian Greenwood, et al.
Published: (2017-05-01)

The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01E vaccination and seasonal malaria chemoprevention versus either intervention given alone
by: Matthew Cairns, et al.
Published: (2022-10-01)

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.
by: Hamma Maiga, et al.
Published: (2016-01-01)

Delivery strategies for malaria vaccination in areas with seasonal malaria transmission
by: Jayne Webster, et al.
Published: (2023-05-01)

Impact of seasonal malaria chemoprevention on hospital admissions and mortality in children under 5 years of age in Ouelessebougou, Mali
by: Djibrilla Issiaka, et al.
Published: (2020-03-01)

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial.
by: Amadou Barry, et al.
Published: (2018-01-01)

Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali
by: Fatou Diawara, et al.
Published: (2017-08-01)

Resurgent and delayed malaria
by: Brian Greenwood, et al.
Published: (2022-03-01)

Monitoring of the Sensitivity In Vivo of <i>Plasmodium falciparum</i> to Artemether-Lumefantrine in Mali
by: Modibo Diarra, et al.
Published: (2021-01-01)

Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali
by: Toure Ousmane B, et al.
Published: (2008-07-01)

Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali
by: Nafomon Sogoba, et al.
Published: (2016-04-01)

Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali and Niger
by: Anyirékun Fabrice Somé, et al.
Published: (2022-08-01)

Effect of seasonal malaria chemoprevention plus azithromycin on Plasmodium falciparum transmission: gametocyte infectivity and mosquito fitness
by: Koudraogo Bienvenue Yaméogo, et al.
Published: (2021-07-01)

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
by: Almahamoudou Mahamar, et al.
Published: (2022-02-01)

Adapting malaria clinical trials infrastructure to implement COVID-19 epidemiology studies: Response to a public health emergency amid safe continuation of a research enterprise
by: John Woodford, et al.
Published: (2022-07-01)

Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso
by: Yves Daniel Compaoré, et al.
Published: (2021-01-01)

Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
by: Matthew Cairns, et al.
Published: (2021-09-01)

Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali
by: Coulibaly Oumar M, et al.
Published: (2010-01-01)

Stratification at the health district level for targeting malaria control interventions in Mali
by: Mady Cissoko, et al.
Published: (2022-05-01)

Sub-national tailoring of seasonal malaria chemoprevention in Mali based on malaria surveillance and rainfall data
by: Mady Cissoko, et al.
Published: (2022-08-01)

Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
by: Ellis Ruth D, et al.
Published: (2010-06-01)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
by: Palang Chotsiri, et al.
Published: (2019-01-01)

Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
by: Almahamoudou Mahamar, et al.
Published: (2021-01-01)

Impact of Three-Year Intermittent Preventive Treatment Using Artemisinin-Based Combination Therapies on Malaria Morbidity in Malian Schoolchildren
by: Hamma Maiga, et al.
Published: (2020-09-01)

Plasmodium falciparum msp1 and msp2 genetic diversity and allele frequencies in parasites isolated from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso
by: Anyirékun Fabrice Somé, et al.
Published: (2018-05-01)

Parasitological Observations on Prevalence, Seasonality and Transmission of Malaria among Tribals of Surguja District
by: Chand Gyan, et al.
Published: (2001-01-01)

Effect of seasonal malaria chemoprevention in children between 5 and 9 years old in Kita and Bafoulabe districts, Mali
by: Sory Ibrahima Diawara, et al.
Published: (2022-08-01)

Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated <it>falciparum </it>malaria across Africa: a randomized multi-centre trial
by: Djimdé Abdoulaye, et al.
Published: (2009-04-01)

Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso.
by: Alphonse Ouédraogo, et al.
Published: (2013-01-01)

Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine
by: Guindo Aldiouma, et al.
Published: (2011-01-01)

Baseline malarial and nutritional profile of children under seasonal malaria chemoprevention coverage in the health district of Nanoro, Burkina Faso
by: Paul Sondo, et al.
Published: (2023-01-01)

Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village
by: Ouattara Amed, et al.
Published: (2006-11-01)

Malaria knowledge, attitude, and practice among communities involved in a seasonal malaria chemoprevention study in Nanyumbu and Masasi districts, Tanzania
by: Billy Ngasala, et al.
Published: (2023-02-01)

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali
by: Wele Mamadou, et al.
Published: (2009-02-01)

Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso.
by: Rachidatou Compaoré, et al.
Published: (2017-01-01)

A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
by: Souleymane Dama, et al.
Published: (2018-10-01)

<it>Plasmodium falciparum </it>clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali
by: Djimde Abdoulaye, et al.
Published: (2010-11-01)

Cost of introducing and delivering malaria vaccine (RTS,S/AS01E) in areas of seasonal malaria transmission, Mali and Burkina Faso
by: Jean Bosco Ouédraogo, et al.
Published: (2023-04-01)